Latest Breaking News On - Head of international at rhythm - Page 1 : vimarsana.com

Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome

BOSTON, Feb. 07, 2024 Rhythm Pharmaceuticals, Inc. , a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare.

United statesUnited kingdomAdam daleyDavid connollyYann mazabraudDrug administrationBerry company public relationsGazzetta ufficialeCorporate communicationsRhythm pharmaceuticals incHead of international at rhythmRhythm pharmaceuticalsEuropean unionItalian medicine agencyMedicines healthcare products regulatory agencyEuropean commission

Rhythm Pharmaceuticals Announces Completion of Screening

Phase 3 hypothalamic obesity top-line data expected in 1H2025 Positive reimbursement decision achieved for IMCIVREE® (setmelanotide) to treat.

United kingdomUnited statesDavid meekerYann mazabraudDavid connollyAdam daleyMinistry of healthRhythm pharmaceuticals incEuropean commissionRhythm pharmaceuticalsExchange commissionBerry company public relationsEuropean unionCompany investigational new drugHead of international at rhythmCorporate communications

Rhythm Pharmaceuticals Announces Completion of Screening for Enrollment in Setmelanotide Phase 3 Hypothalamic Obesity Trial and Additional Updates

Phase 3 hypothalamic obesity top-line data expected in 1H2025 Positive reimbursement decision achieved for IMCIVREE® to treat patients with Bardet-Biedl syndrome and POMC/LEPR.

United kingdomUnited statesAdam daleyYann mazabraudDavid connollyDavid meekerCorporate communicationsUnited kingdom medicines healthcare products regulatory agencyBerry company public relationsEuropean unionCompany investigational new drugHead of international at rhythmEuropean commissionExchange commissionRhythm pharmaceuticalsMinistry of health

Rhythm Pharmaceuticals (RYTM) Provides Business Update

Rhythm Pharmaceuticals (RYTM) Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesDavid meekerYann mazabraudRhythm pharmaceuticals incHead of international at rhythmEuropean unionMinistry of healthCompany investigational new drugUnited kingdom medicines healthcare products regulatory agencyRhythm pharmaceuticalsEuropean commissionChief executive officerReimbursement decisions achievedExecutive vice presidentInvestigational new drug

Rhythm Pharmaceuticals (RYTM) Granted Orphan Drug Designation in EU for Setmelanotide for Treatment of Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals (RYTM) Granted Orphan Drug Designation in EU for Setmelanotide for Treatment of Acquired Hypothalamic Obesity
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomYann mazabraudEuropean unionHead of international at rhythmEuropean medicines agencyRhythm pharmaceuticals incRhythm pharmaceuticalsExecutive vice president